BIB icon

ProShares Ultra NASDAQ Biotechnology

30 hedge funds and large institutions have $18.6M invested in ProShares Ultra NASDAQ Biotechnology in 2020 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 8 increasing their positions, 7 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
30
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$7.58M
Puts
$6.62M
Net Calls
Net Calls Change

Top Buyers

1 +$3.45M
2 +$2.07M
3 +$1.76M
4
Citadel Advisors
Citadel Advisors
Florida
+$1.29M
5
UBS Group
UBS Group
Switzerland
+$797K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$3.88M
2
$3.47M
3
$2.51M
4
$1.76M
5
$1.76M
6
$1.51M
7
$927K
8
$797K
9
$421K
10
$380K
11
$295K
12
$210K
13
$141K
14
$115K
15
$105K
16
$105K
17
$66K
18
$35K
19
$19K
20
$17K
21
$14K
22
$14K
23
$13.6K
24
$13K
25
$6K